Can low estradiol in men be interpreted without testosterone, SHBG, LH, and FSH?

Biological mechanisms of estradiol production

• Physiological substrate dynamics: In men, approximately 80% of circulating estradiol is derived from the peripheral aromatization of testosterone. While the aromatase enzyme (CYP19A1) biochemically exhibits a lower $K_m$ and higher catalytic efficiency for androstenedione, testosterone’s high systemic abundance in male physiology makes it the primary physiological substrate for estradiol synthesis.
• Enzymatic conversion: Aromatase acts as the rate-limiting enzyme in this pathway. Because conversion occurs largely in peripheral tissues, alterations in adipose tissue volume directly influence hormone levels; increased adiposity upregulates aromatase expression, accelerating the conversion of testosterone to estradiol. Conversely, pharmacological intervention with aromatase inhibitors binds to and blocks the enzyme, suppressing estradiol synthesis.

Clinical evaluation and diagnostic signaling

• Substrate availability: Because estradiol is a downstream product of testosterone, isolated low estradiol measurements (<10–20 pg/mL) are clinically uninterpretable without assessing precursor availability. Measuring total and free testosterone determines whether low estradiol is simply due to a lack of upstream substrate.
• Binding and bioavailability: Sex hormone-binding globulin (SHBG) binds tightly to both testosterone and estradiol, governing their bioavailable free fractions. Elevated SHBG levels—often seen with aging—can severely restrict the free, biologically active fraction of estradiol, potentially causing cellular-level deficiency symptoms even when total estradiol concentrations fall within normal reference ranges.
• Central signaling vs. primary failure: Incorporating gonadotropins (LH and FSH) into the diagnostic panel is essential to localize the pathology:
  • Primary hypogonadism (testicular failure): Characterized by elevated LH and FSH levels in response to the lack of negative feedback from low testosterone and estradiol.
  • Secondary hypogonadism (hypothalamic/pituitary failure): Characterized by low or inappropriately normal LH and FSH levels, indicating a central signaling defect.

Bottom line

Low estradiol in men cannot be interpreted as an isolated metric. Accurate clinical assessment requires a comprehensive panel including total testosterone, free testosterone, SHBG, LH, and FSH to differentiate between substrate deficiency, transport binding alterations, and central signaling failures.